OrganiGram Holdings Inc. (OGI)
NASDAQ: OGI · IEX Real-Time Price · USD
1.880
-0.035 (-1.83%)
At close: May 2, 2024, 4:00 PM
1.920
+0.040 (2.13%)
After-hours: May 2, 2024, 7:56 PM EDT
OrganiGram Holdings Revenue
Revenue in the quarter ending December 31, 2023 was $27.41M, a -15.85% decrease year-over-year. In the fiscal year ending September 30, 2023, OrganiGram Holdings had annual revenue of $119.73M with 6.75% growth.
Revenue (ttm)
$119.73M
Revenue Growth
+6.75%
P/S Ratio
n/a
Revenue / Employee
$121,679
Employees
984
Market Cap
176.90M USD
Revenue Chart
* The company reports in CAD currency but revenue data is shown in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2023 | 119.73M | 7.57M | 6.75% |
Aug 31, 2022 | 112.16M | 48.83M | 77.10% |
Aug 31, 2021 | 63.33M | -2.42M | -3.69% |
Aug 31, 2020 | 65.75M | 5.29M | 8.75% |
Aug 31, 2019 | 60.46M | 51.04M | 542.11% |
Aug 31, 2018 | 9.42M | 5.10M | 118.41% |
Aug 31, 2017 | 4.31M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Semler Scientific | 68.18M |
Genfit | 42.42M |
Compugen | 33.46M |
bluebird bio | 21.73M |
Cellectis | 9.19M |
Profound Medical | 5.41M |
OGI News
- 4 weeks ago - Organigram's Popular SHRED Brand Surpasses $200 Million in Yearly Retail Sales - Business Wire
- 4 weeks ago - Everything Golden for Nexsan on Eve of Silver Anniversary - Business Wire
- 4 weeks ago - Organigram Successfully Closes Previously Announced Underwritten Public Offering - Business Wire
- 5 weeks ago - Organigram Announces Pricing of Overnight Marketed Public Offering - Business Wire
- 5 weeks ago - Organigram Announces Launch of Overnight Marketed Public Offering - Business Wire
- 5 weeks ago - Organigram Invests in U.S. Based Open Book Extracts Representing Inaugural Jupiter Investment - Business Wire
- 5 weeks ago - The Marijuana Stocks Could See A Rise This Week - MarijuanaStocks
- 5 weeks ago - Organigram Receives Health Canada's Final Redetermination on Jolts - Business Wire